Teleflex Incorporated (NYSE:TFX) Receives $267.50 Consensus Price Target from Analysts

Teleflex Incorporated (NYSE:TFX) has been assigned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $267.50.

Several brokerages have issued reports on TFX. Truist Financial cut their target price on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a research note on Friday, February 23rd. JMP Securities reissued a “market outperform” rating and set a $285.00 target price on shares of Teleflex in a research note on Friday, February 23rd. Royal Bank of Canada cut their target price on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a research note on Friday, February 23rd. Finally, StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd.

Insider Buying and Selling

In related news, VP Cameron P. Hicks sold 7,401 shares of the company’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the completion of the sale, the vice president now directly owns 10,050 shares in the company, valued at $2,261,250. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.43% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Teleflex

A number of large investors have recently bought and sold shares of the business. Kentucky Retirement Systems boosted its holdings in Teleflex by 1.1% during the fourth quarter. Kentucky Retirement Systems now owns 3,760 shares of the medical technology company’s stock valued at $938,000 after acquiring an additional 42 shares during the period. Commonwealth Equity Services LLC boosted its holdings in Teleflex by 0.9% during the first quarter. Commonwealth Equity Services LLC now owns 4,688 shares of the medical technology company’s stock valued at $1,187,000 after acquiring an additional 42 shares during the period. Venturi Wealth Management LLC boosted its holdings in Teleflex by 33.3% during the fourth quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock valued at $46,000 after acquiring an additional 46 shares during the period. Mercer Global Advisors Inc. ADV boosted its holdings in Teleflex by 3.5% during the third quarter. Mercer Global Advisors Inc. ADV now owns 1,411 shares of the medical technology company’s stock valued at $284,000 after acquiring an additional 48 shares during the period. Finally, First Horizon Advisors Inc. boosted its holdings in Teleflex by 39.1% during the first quarter. First Horizon Advisors Inc. now owns 178 shares of the medical technology company’s stock valued at $45,000 after acquiring an additional 50 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Teleflex Price Performance

NYSE TFX opened at $206.56 on Friday. The stock has a market capitalization of $9.73 billion, a P/E ratio of 27.43, a P/E/G ratio of 1.98 and a beta of 1.11. Teleflex has a 1 year low of $177.63 and a 1 year high of $276.43. The business’s fifty day moving average is $225.49 and its two-hundred day moving average is $225.58. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.29 and a current ratio of 2.32.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.26 by $0.12. The company had revenue of $773.90 million for the quarter, compared to analysts’ expectations of $769.01 million. Teleflex had a return on equity of 14.98% and a net margin of 11.98%. The firm’s revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.52 earnings per share. On average, research analysts forecast that Teleflex will post 13.73 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, March 1st were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend was Thursday, February 29th. Teleflex’s dividend payout ratio is currently 18.06%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.